Engaging at Risk Populations in Vaccine Preparedness Research
|
|
- Jodie McCoy
- 8 years ago
- Views:
Transcription
1 Engaging at Risk Populations in Vaccine Preparedness Research Presentation by Annie Madden AIVL Executive Officer Hepatitis C Vaccine Initiative Workshop (Sydney) 15 October 2008 I have been asked to talk today about engaging risk populations in vaccine preparedness research and then was later asked to also include a discussion of the role of community in HCV prevention research (instead of Stuart Loveday) but both of these topics are huge topics in themselves. So, due to time restraints I am going to try to broadly cover off both topics by making some general comments about engaging risk populations in research that affects their lives and some specific comments about vaccine preparedness research in particular. When it comes to hep C vaccine preparedness research, there are numerous at risk populations or sub-populations that could be discussed but I am going to focus on the broad category of people who inject/have injected illicit drugs. In thinking about how to approach this presentation today I have to say that I found myself feeling quite unsure as to where to start and what to say. I know little or nothing about immunology, clinical research studies or vaccine development. In this context it was hard to know what I could really contribute to the discussion today. From where I stand as someone with chronic hepatitis C infection and as someone who has worked for many years to represent the issues for people affected by hepatitis C, I have to admit that I have actually given very little thought to the issue or prospect of a hepatitis C vaccine. This realisation led me to speak with some of my colleagues at AIVL and some local drug users about their thoughts and reactions to the issue of a hepatitis C vaccine. What I got back was a very interesting level of what can best be called: ambivalence about the whole subject. The more I thought about this response, the more I realised that it was hardly surprising in that this ambivalence largely reflected the general nature of the clinical relationship between drug users and the health system. That is, a general sense of ambivalence about health and the health system which develops almost as a protective function in response to disempowerment, the impact of stigma and discrimination, poor treatment, a lack of access to appropriate services and a general sense that you have very little control over or say in your health or the way you are treated by the health system at any given time. After all if you are treated badly by your methadone program or by doctors why would you expect anything better from any other part of the health system? This is the fundamental backdrop to any hepatitis C vaccine initiative. The departure point with the most at risk population in relation to hepatitis C, that is people who inject or have injected drugs, is one of overwhelming disempowerment and disengagement. Drug users are a highly researched group of people and in this context, it is probably fair to say that most people feel at best, research subjects, rather than as active participants in a joint-investigative process. For all the research drug users participate in, unless you happen to work at or are active in a drug user organisation, it is very unlikely that you will ever see the results of any research you participate in.
2 This is very important in the context of hepatitis C vaccine research because rightly or wrongly, there is a strong impression out there that too often research relating to drug users lives, promises a great deal but rarely seems to deliver. Now, if you are a researcher in this area that may well seem like a harsh comment particularly given the many factors that can intervene on the implementation and impact of research, but at the end of the day, it is not whether the comment is fair or not that I want to focus on, what I want to highlight is that there is a high degree of scepticism and research fatigue among many drug users and this needs to be taken into account if you are seeking to conduct research involving drug users. Engaging marginalised and socially isolated people as active participants in a research process is very difficult at the best of times. But convincing people who distrust the health system, often for good reason, that it is in their best interests to participate in the development of a hep C vaccine might be best described as an uphill battle. That doesn t mean to say that a process of engagement should not be pursued, but it does mean that there are a number of important factors that need to be properly understood and acknowledged as part of any engagement process in relation to hep C vaccine development and these are: 1. Understanding the context of people s lives many drug users are dealing with multiple complex and competing priorities in their lives at any given time. These issues can greatly affect their ability to engage with services and researchers but can also impact on the priority they give to an issue in their lives such as hepatitis C. For example, it may be quite enough for someone doing a prison term to manage their daily survival and cope with life prison without feeling like they are being encouraged to participate in research about hep C prevention or development of a vaccine lest they be seen as a difficult and non-compliant prisoner. These types of pressures don t have to be real in the sense that they are explicit. It is enough that the person feels the weight of such expectations when they are in an extremely powerless position. As a researcher it is very important to not only understand but genuinely accept that the targets of your research may not be as interested as you are in your research! Just because something is theoretically a priority for a particular group in the community doesn t mean it is actually a priority for that group or that it will be seen as a priority by all members of that group. Indeed, AIVL has at times received quite negative, even hostile responses from researchers if we don t get sufficient participants for their research when they ask or if we are just not as enthusiastic or interested in their research as they are. Sometimes we (AIVL and drug users for that matter) just have different priorities than researchers even if it is perceived as a pressing health issue. 2. Understanding that some people are very sceptical about large pharmaceutical companies and mega research hubs or initiatives due to experiences with other clinical research trials and programs in relation to methadone, pain relief, interferon, etc drug users are used to being given whatever is cheapest, whatever is easiest to deliver on mass and at times (think interferon) virtually whatever is lying around when it comes to treatments. It is not surprising then, that some drug users may not be sure they can trust large vaccine initiatives to look out for their safety. We have seen examples of vaccine development research and trials going very wrong (re: HIV candidate vaccines making people more not less susceptible to HIV infection they didn t expect it, they still don t really know why it happened, but it did and people, vulnerable people, have been left worse off as a consequence). People hear
3 about such outcomes and are naturally very scared and distrustful of a health system that has done little to win their trust over the years with less harmful medications let alone vaccines. There also examples in Asia with HIV vaccine trials where highly vulnerable groups of drug users have been exploited by poor research standards and controls. Where drug users rightly or wrongly got the message that their participation in the methadone program was contingent upon their participation in the vaccine trial. Concerns about a lack of informed consent are very real in this context. 3. Researchers need to be mindful that it can be very hard for people to get interested in a vaccine for a disease they can t see, is not making them ill or where they can see their friends with hep C doing OK. Researchers involved in hep C preparedness studies need to understand why people might opt out of such a study or at the very least be ambivalent or disinterested. For some people it will be a question of why take the risk of being involved in development of a hep C vaccine that could go horribly wrong or just go nowhere when there are so many other issues that I need to address in my life, right here, right now or even just so many other issues that I would like to see researched or action taken on such as more pharmacotherapy options, heroin trials, etc. But I need to stress here, despite having outlined a number of reasons why people might not engage in hep C vaccine preparedness research, it is also very important to talk about those drug users who will be interested in such engagement because some drug users will be genuinely interested in research that affects their lives: 4. Researchers need to be extremely careful about setting up unrealistic expectations of vaccine development or just the danger of misinformation and how that can impact on a person s or even a whole network s protective behaviours. Many years of work has gone into strategies for getting accurate information to drug users about hep C and supporting people to engage in safer practices and blood awareness. Information in relation to hep C vaccine development is very complex and there is a very real risk of misinformation people thinking a vaccine is just around the corner when it is not, changing their practices based on incorrect assessments about what a hep C vaccine might do if and when such a vaccine is developed and available, etc. This a major research ethics and responsibility issue for any researcher involved in or seeking to engage at risk communities/populations on the issue of hep C vaccine preparedness and one which a great deal of thought and work needs to go into before researchers even think about talking with active drug users about the possibility of hep C vaccines. Damage can so easily be done but very difficult to undo once misinformation and/or unsafe practices take hold. 5. Linked to the issue of raising false hopes are questions about the role of people who already have hep C in any hep C vaccine preparedness research. Now of course the answer to this question depends on whether the candidate vaccine is a preventative or therapeutic vaccine and many other questions besides but, the fact is, that in developing this presentation, a number of drug users with hep C stated to me that they weren t interested in the hep C vaccine issue because it would be no good for them even if a vaccine was to be developed. A number of people expressed sentiments along the lines of being thrown on the health system scrapheap if an effective hep C vaccine was ever available and that
4 they expected they would experience even higher levels of stigma and discrimination than they do now. I think this is a really important issue for researchers in Hep C vaccine preparedness as it will be an unspoken reason why people will withdraw from engagement in the research as they will simple see it was another way for them to be seen as at best irrelevant and at worse, the problem that everyone needs to be vaccinated against. 6. Where researchers seek to access people to participate in their research, particularly in clinical research like vaccine studies is also very important. It is critical to recognise the diversity of people who inject drugs and don t simply seek to access participants in the usual places and services such as NSPs, drug treatment services, etc. This is particularly when discussing hep C vaccine research that is looking to recruit a rolling cohort of hundreds of hep C negative people. Participants will need to be recruited from a diversity of venues and places to ensure a broad cross-section of drug users who are hep C negative. It is also important to ensure the space is safe for the participant both in terms of privacy and confidentiality and in relation to enough space and appropriate support to make an informed decision about something as important as going on a clinical trial for a new vaccine. The role of trained and supported peers is crucial to assist with the education and informed consent process for such research. 7. It is also important to consider whether the development of a hep C vaccine or even talk of a possible hep C vaccine can erode support for critical harm reduction programs like NSP? These programs are difficult to gain and retain political support for in the best of political circumstances they are extremely vulnerable programs and any researcher working in the area of hep C vaccine preparedness needs to take very seriously the potential negative impact that talk of a hep c vaccine could have on access to these critical programs for those who need them. The main concern is whether even possible availability of a hep C vaccine could lead to funding being pulled from NSP in favour of funding for a more palatable technological fix such as a vaccine. While I know that some think it is too early to be even raising issues such as these given that an actual vaccine will be many years away (if ever) but I believe it is never too early to begin thinking about the potential policy impacts of any research initiative. If you are talking to people about the vaccine initiative then it is not too early. 8. I couldn t conclude a discussion about engaging IDU in hep C vaccine preparedness research without reflecting on the issue of hepatitis B vaccination. We know that drug users are not really engaged on the issue of vaccination. We have a perfectly acceptable vaccine for hep B but still many drug users are not vaccinated why? There are numerous reasons that mostly relate to lack of access to primary health care, distrust of the health system, poor experiences of the health system, lack of access to information about hep B and hep B vaccination and the competing priorities in people s lives that prevent them from engaging on many issues. In relation to hep C vaccine preparedness research there is much we can learn from the hep B vaccination experience with IDU including: a. The need to engage people in the development process from day one which is why involvement of drug user organisations in workshops like this one is so important. It is also why the social research arm of the vaccine initiative is so
5 important because it is where the views of ordinary drug users and their attitudes to hep C vaccination can be identified. b. Providing better access to information on hepatitis C and the possibilities for a hep C vaccine. People are not stupid, not everyone will be interested but for those who are there needs to be easy to access, accurate, credible, balanced and accessible information on hep C vaccine developments to prevent misinformation and to empower people to decide for themselves what level or sort of engagement they want to have on this issue if any. c. We also need to learn from the delivery problems associated with the hep B vaccination schedule involving 3 injections over a long period of time. Long and complex vaccination schedules will never work for a group of people who have very poor access to health services. Any hep C vaccine will need to address this problem with preferably a one injection schedule. Issues of protection over time and whether people will need booster vaccines will also need to be addressed effectively if barriers to a hep C vaccine are to be removed. d. But finally, we need to get serious about addressing the fundamental reasons why drug users do not access hep B vaccinations, other available treatments and are often reluctant to engage with research and that is because they have appalling access to good quality, non-judgemental primary health care. Drug users carry a fundamental distrust of the health system based on routine discrimination and poor quality treatment. Until we address this we will never increase access or engagement. After all, as hep B vaccination has shown, there is no point in putting all the work into developing an effective and safe vaccine if those who could most benefit, do not benefit because there are structural inequities that prevent access. Having said all of that however, this does not mean that AIVL is anti-vaccine or anti-vaccine preparedness research per se. I am saying however, that it is really important that those engaged in vaccine research don t get so caught up that you forget that at the end of the day all of this is about people. I can imagine that it is tempting when you are working on the edge of scientific discovery that it could be very easy to just to closet yourself with other clinical researchers who understand you, who get you and what you are trying to achieve. But sooner or later it has to come back to people people for clinical trials, people to take the vaccine. And when we are talking about a vaccine for hepatitis C we are talking about some extremely vulnerable people who are relying on all of you to do the right thing by them, to ensure what you do is done ethically. In the end I am left quite unsure about the hep C vaccine issue. Investing multi-million dollar budgets into hep C vaccine research when we don t have enough funding to undertake hepatitis C prevention properly, when we aren t funding NSP adequately to ensure there is a new fit available for every injection that happens when we can do this, maybe the issue of hep C vaccine will be more of a priority. At the end of the day I keep coming back to the fact that we need to get hep C prevention right because even without a vaccine hepatitis C is a preventable virus.
A handbook for people who have injected drugs
A handbook for people who have injected drugs Introduction This handbook has been written for current and ex-drug injectors. It gives information and advice about the hep C virus, and the tests you can
More informationCase study 1 - Eileen, 69: A disagreement with a hospital doctor led to the doctor refusing to continue treatment.
Case studies 1-7: Please note these are fictional case studies from the GMC s Patients help web section, to help patients understand about the process for complaining about a doctor. Case study 1 - Eileen,
More informationGetting help for a drug problem A guide to treatment
Getting help for a drug problem A guide to treatment Who we are The National Treatment Agency for Substance Misuse is part of the National Health Service. We were set up in 2001 to increase the numbers
More informationReturning to Work is a Lot of Work
Returning to Work is a Lot of Work Back in Motion Rehab Inc. January 2014 Returning to Work is a Lot of Work! There are a lot of reasons people have to take time off work. Sometimes people experience injuries
More informationNew Beginnings: Managing the Emotional Impact of Diabetes Module 1
New Beginnings: Managing the Emotional Impact of Diabetes Module 1 ALEXIS (AW): Welcome to New Beginnings: Managing the Emotional Impact of Diabetes. MICHELLE (MOG): And I m Dr. Michelle Owens-Gary. AW:
More informationEmployee Assistance Programmes Manager s Guide
March 2012 Employee Assistance Programmes Manager s Guide Support and assistance when you need it Vhi Corporate Solutions Employee Assistance Programme Confidential Professional Help Support Communicate
More informationGROUND UP. Insite was specifically designed to be accessible to
Vancouver s Supervised Injection Site s Role in Accessing Treatment and Care GROUND UP Canada has long been regarded as a global leader in health care delivery and innovation. Since September 2003, Insite,
More informationdrug treatment in england: the road to recovery
The use of illegal drugs in England is declining; people who need help to overcome drug dependency are getting it quicker; and more are completing their treatment and recovering drug treatment in ENGlaND:
More informationNovember 2014 March 2015
November 2014 March 2015 April 2015 1 Executive Summary & Acknowledgements Background Aims Objectives National context Local context - Trafford School Nurse Service Methodology Project Outline Firs Primary
More informationSuicidal. Caring For The Person Who Is. Why might a person be suicidal?
Caring For The Person Who Is Suicidal For further information see also the following MIND Essentials resource Conducting a suicide risk assessment. Suicidal thoughts and behaviours are not unique to mental
More informationPsychic Guide 101 Written by: Jennifer A. Young www.bestonlinepsychics.net
Written by: Jennifer A. Young www.bestonlinepsychics.net Page 1 Table of Contents Chapter Title Page 01 Consulting a Psychic 03 02 Why Should You Consult a Psychic? 04 03 What Is a Psychic? 05 04 Choosing
More informationScientific Facts on. Psychoactive Drugs. Tobacco, Alcohol, and Illicit Substances
page 1/5 Scientific Facts on Psychoactive Drugs Tobacco, Alcohol, and Illicit Substances Source document: WHO (2004) Summary & Details: GreenFacts Context - Psychoactive drugs such as tobacco, alcohol,
More informationINTERVIEW QUESTIONS: ADVICE AND GUIDANCE
INTERVIEW QUESTIONS: ADVICE AND GUIDANCE Although interviews can vary tremendously, from an informal chat to a panel interview, some questions always seem to crop up. It would be a good idea to review
More informationThe Good medical practice framework for appraisal and revalidation
The Good medical practice framework for appraisal and revalidation The framework sets out the broad areas which should be covered in medical appraisal and on which recommendations to revalidate doctors
More informationClinical Trials. Clinical trials the basics
Clinical Trials Clinical Trials This brochure is for people making decisions about cancer treatment. You may be thinking about a clinical trial for you or your child but need to know more before you decide.
More information13. Project Management and the Australian Bureau of Statistics: Doing What Works
13. Project Management and the Australian Bureau of Statistics: Doing What Works Dennis Trewin, Australian Statistician, Australian Bureau of Statistics Introduction Project management has to be a core
More informationMaking the most of Work Experience
Making the most of Work Experience This guide is part of the Getting Started series. For more guides in the series please visit the website below. www.twitter.com/mmu_careers www.facebook.com/careersmmu
More informationRights Advocacy Recovery Voices Rights Advocacy Recovery Voices Rights Advoca Recovery Voices Rights Advocacy Recover.
Recovery Voices Rights Advocacy Recov Voices Rights Advocacy Recovery Voices Rights Advocacy Recovery Voices Rights Advocacy Recovery Voices Rights Advoca Recovery Voices Rights Advocacy Recover Voices
More informationQuick guide to the employment practices code
Data protection Quick guide to the employment practices code Ideal for the small business Contents 3 Contents Section 1 About this guidance 4 Section 2 What is the Data Protection Act? 5 Section 3 Recruitment
More informationYoung homeless people on healthcare. The views of the National Youth Reference Group
Young homeless people on healthcare The views of the National Youth Reference Group Introduction The Queen s Nursing Institute s Homeless Health Project visited the St Basil s Charity in Birmingham in
More informationWhat Cancer Patients Need To Know
Taking Part in Clinical Trials What Cancer Patients Need To Know NATIONAL INSTITUTES OF HEALTH National Cancer Institute Generous support for this publication was provided by Novartis Oncology. Taking
More informationThe Cushman Report 2016, Volume 1
Added Value Recruiting and Consulting Search Services in Corporate Communications The Cushman Report 2016, Volume 1 In this newsletter: Taking a Fresh Look at the hiring process for Communications VPs,
More informationHepatitis Services in Substance Abuse Treatment Settings
Hepatitis Services in Substance Abuse Treatment Settings Funding provided by the Center for Substance Abuse Treatment The Matrix Institute Dan George Overview Hx of HCV group s implementation at OTP clinic
More informationResearch to Practice Series
Institute of Child Protection Studies 2 Identity and meaning in the lives of vulnerable young people The Institute of Child Protection Studies links the findings of research undertaken by the Institute
More informationwww.arden Fumigation.com (408) 279-2040 1
1 FREE REPORT 5 Crucial Things You Should Know Before Choosing a Pest Control Service 2 We all know how difficult it is when we need to get rid of pests in our house. It is even more difficult to do it
More informationTen Steps to Success in New Business Ventures
by Matthew Simmons part-time Marketing Director Introduction Let's set the scene - you are an entrepreneur who has invented a great idea, or perhaps you are a manager in a larger organisation who is about
More informationDESCRIBING OUR COMPETENCIES. new thinking at work
DESCRIBING OUR COMPETENCIES new thinking at work OUR COMPETENCIES - AT A GLANCE 2 PERSONAL EFFECTIVENESS Influencing Communicating Self-development Decision-making PROVIDING EXCELLENT CUSTOMER SERVICE
More informationWhy Sales Training Doesn t Work....and what to do about it!
Why Sales Training Doesn t Work...and what to do about it! Selling isn t a great sport in which to come second. In the world of winner takes all, anything that gives you a small increase in performance
More informationCreating an Awesome Customer Experience
Creating an Awesome Customer Experience The need to provide a great customer experience. To have profitable customers who stay with you a long time, your goal must be to create the kind of experience that
More informationInformation about hepatitis C for patients and carers
Information about hepatitis C for patients and carers What is hepatitis C? Hepatitis C is an illness caused by a virus which can be passed through blood from one person to another. It mainly affects the
More informationHelping Someone who has Problems with Alcohol
Helping Someone who has Problems with Alcohol Alcohol is one of the most commonly used drugs in our society. It is legal and a depressant, impacting on the brain to affect mood, emotion, co-ordination,
More informationPreventing bullying: a guide for teaching assistants. SEN and disability: developing effective anti-bullying practice
Preventing bullying: a guide for teaching assistants SEN and disability: developing effective anti-bullying practice Preventing bullying: a guide for teaching assistants 2 Introduction This guide is based
More informationResearch Ethics Review Committee (WHO ERC)
Research Ethics Review Committee (WHO ERC) 20, AVENUE APPIA CH-1211 GENEVA 27 SWITZERLAND HTTP://INTRANET.WHO.INT/HOMES/RPC/ERC HTTP://WWW.WHO.INT/RPC/RESEARCH_ETHICS Informed Consent Template for Clinical
More informationConsumer Awareness Guide. Using Recruitment Agencies
Consumer Awareness Guide Using Recruitment Agencies Prepared By Ian M Campbell Avenue Scotland Introduction At Avenue Scotland, we take great pride in the honest, professional service we provide. We have
More informationSpecialist Alcohol & Drug Services in Lanarkshire
Specialist Alcohol & Drug Services in Lanarkshire This brochure describes what help is available within Lanarkshire s specialist treatment services. These include the North Lanarkshire Integrated Addiction
More informationWhat is insurance? A guide to help you understand about insurance. By Mencap and Unique Insurance Services. Easy read
What is insurance? A guide to help you understand about insurance By Mencap and Unique Insurance Services Easy read What is insurance? Insurance is a way of guarding against damage or loss of something
More informationdealing with a depression diagnosis
tips for dealing with a depression diagnosis 2011 www.heretohelp.bc.ca No one wants to feel unwell. Talking to your doctor or other health professional about problems with your mood is an important first
More informationTAFE SA Student Alcohol and Other Drug Policy Under the umbrella of Drugs and Alcohol Policy (DFEEST OHS&IM 026)
TAFE SA Student Alcohol and Other Drug Policy Under the umbrella of Drugs and Alcohol Policy (DFEEST OHS&IM 026) 1. Purpose of the policy The purpose of the Student Alcohol and Other Drug Policy is to
More informationBeginner's guide to Hepatitis C testing and immunisation against hepatitis A+B in general practice
Beginner's guide to Hepatitis C testing and immunisation against hepatitis A+B in general practice Dr Chris Ford GP & SMMGP Clinical Lead Kate Halliday Telford & Wrekin Shared Care Coordinator Aims Discuss:
More informationWhen being a good lawyer is not enough: Understanding how In-house lawyers really create value
When being a good lawyer is not enough: Understanding how In-house lawyers really create value Contents Foreword... 3 Do you really understand how In-house lawyers create value?... 4 Why creating value
More informationAlfred Koblinger Proximity Worldwide
Alfred Koblinger Proximity Worldwide Creativity to Hell - We Have to Sell! The crucial question in today s marketing: Too much of the same! Brands and Ads! Image or Behaviour? Threat of Retail Brands.
More informationLessons Learned by engineering students on placement
Lessons Learned by engineering students on placement It is generally acknowledged that students have the opportunity to gain far more than technical knowledge on placement or even the chance to experience
More informationPersonal Information This Wellness Recovery Action Plan belongs to: Name Address City State Zip Telephone E-Mail Special instructions
My WRAP Plan 1995-2005 Mary Ellen Copeland, MS, MA All Rights Reserved P.O. Box 301, West Dummerston, VT 05357 www.mentalhealthrecovery.com Copeland Center for Wellness & Recovery P.O. Box 6464, Chandler,
More informationFor DUI Can Be What Gets You Off.
- Cutting Edge DUI Defense At A Price You Can Afford - Not Guilty Dismissed Reduced The Exact Same Science That Got You Arrested For DUI Can Be What Gets You Off. The Decision You Make Right Now Will Affect
More informationEuropean report on drug consumption rooms Executive summary
Page 1 of 7 European report on drug consumption rooms Executive summary June 2004 Dagmar Hedrich, Project Manager, P2 - Responses General public Introduction The European report on drug consumption rooms
More informationWHAT YOU NEED TO KNOW ABOUT HEPATITIS C: A GUIDE FOR PEOPLE WITH HIV INFECTION
WHAT YOU NEED TO KNOW ABOUT HEPATITIS C: A GUIDE FOR PEOPLE WITH HIV INFECTION Did you know that in the United States, at least 1 in 4 people with HIV is also infected with hepatitis C? Hepatitis C is
More informationHow To Detox At Respite House
Respite House Alcohol Detox Client Information Sheet Cambridgeshire Community Services NHS Trust: delivering excellence in drug services across Luton as part of the ResoLUTiONs Pathway Respite House client
More informationAlcohol & Other Drugs GETTING STARTED
Alcohol & Other Drugs GETTING STARTED 4 This is Booklet 4 in the Getting Started Series. Getting Started is a guide for people leaving prison. Booklets 1 The First Week 2 Housing 3 Identification 4 Alcohol
More informationMANAGING HERPES. Living and loving with hsv. American Social Health association. by Charles Ebel & Anna Wald, M.D., M.P.H.
MANAGING HERPES Living and loving with hsv by Charles Ebel & Anna Wald, M.D., M.P.H. American Social Health association RESEARCH TRIANGLE PARK, NORTH CAROLINA contents contents Preface xi Acknowledgments
More informationHas the penny DR PPED? Our tenants attitudes towards money and the implications for welfare reform INANCIAL INCLUSION
Has the penny DR PPED? Our tenants attitudes towards money and the implications for welfare reform INANCIAL INCLUSION Contents Foreword from Mark Rogers, Group Chief Executive 4 Executive Summary 5 The
More informationSupporting Children with Mental Health Issues and their Families MARIE HARRINGTON ASWTL CUH
Supporting Children with Mental Health Issues and their Families MARIE HARRINGTON ASWTL CUH The number one health issue for young people is their mental health Mental Health has been defined as a state
More informationQuestions often asked by patients and answers from the Randolph Surgery
Questions often asked by patients and answers from the Randolph Surgery 1. Why does the Randolph Surgery insist that everyone over 40 (or anyone who requires prescribed medication under 40) has a comprehensive
More informationReflective Writing. How do you write reflectively? Stages of reflective thinking
Reflective Writing Reflective Writing There are a variety of reasons you might need to write reflectively. When you apply for jobs, undertake self-evaluation at work or whilst studying, or when writing
More informationThe How, What, When and Why of On-Boarding
The How, What, When and Why of On-Boarding An ebook By Debbie Edmondson Cohesion Recruitment What is On-boarding? On-boarding is a really key part of your engagement process, and needs organisational buy-in
More information7 Excuses Salespeople Make For Not Achieving Targets. ..and how to manage a better result!
7 Excuses Salespeople Make For Not Achieving Targets..and how to manage a better result! by David Penglase B.Bus(HRD) MBA MPE www.salescoachcentral.com Liability Disclaimer: The information provided in
More informationMoney and the Single Parent. Apprisen. 800.355.2227 www.apprisen.com
Money and the Single Parent Apprisen 800.355.2227 www.apprisen.com Money and the Single Parent Being a single parent is not easy. As a matter of fact, it is really hard. Single parents are stretched in
More informationDAYS. Drug & Alcohol Youth Support
DAYS 1 Drug & Alcohol Youth Support What is Cannabis? Cannabis is a mildly hallucinogenic drug that comes from the cannabis plant. The main active compound in cannabis is Tetrahydo-cannabinol (THC). Where
More information'RLQJ WKH ULJKW WKLQJ
The Severn Trent way 2011 These are our principles. They help us all understand how to think about the actions and decisions we have to take every day. This way, we remain who we want to be and always
More informationQuestions about your pain medicines
Questions about your pain medicines This information is an extract from the booklet Controlling cancer pain. You may find the full booklet helpful. We can send you a free copy see page 6. Contents Common
More informationGrief is the outcome of loving and losing someone in life. It is a common human experience.
Grief after loss Grief is our reaction to loss. When we lose something that we are attached to, or love, the reaction we experience is what is known as grief. While we can talk about the reactions others
More information5 costly mistakes you should avoid when developing new products
5 costly mistakes you should avoid when developing new products By Paul Forsythe Managing Director at Alemare Solutions And Product Development expert with 25 years experience Hello, As you will know,
More informationContents. Before you begin. How to work through this learner guide Assessment. Introduction: Reflecting on and improving own professional practice
Contents Contents Before you begin How to work through this learner guide Assessment Introduction: Reflecting on and improving own professional practice v v vi 1 Chapter 1: Reflecting on your practice
More informationACCESS TO JUSTICE: A COMPARATIVE ANALYSIS OF CUTS TO LEGAL AID THE CHANGING FACE OF THE LEGAL PROFESSION
ACCESS TO JUSTICE: A COMPARATIVE ANALYSIS OF CUTS TO LEGAL AID THE CHANGING FACE OF THE LEGAL PROFESSION A short paper presented on 19 th March 2014 to a symposium organised by the University of Warwick
More informationInternal Mediation Services. Surrey County Council in partnership with South East Employers
Internal Mediation Services Surrey County Council in partnership with South East Employers Introduction and Summary Surrey County Council s cultural strategy is clear it wants to create a coaching culture
More informationTime Management & Stress Reduction
Time Management & Stress Reduction What is stress? Stress is your body s reaction to the things which you perceive as pressures. Stress occurs when you feel that you cannot cope with those pressures. Our
More informationClinical Trials: What You Need to Know
Clinical Trials: What You Need to Know Clinical trials are studies in which people volunteer to test new drugs or devices. Doctors use clinical trials to learn whether a new treatment works and is safe
More informationParenting. Coping with A Parent s Problem Drug or Alcohol Use. For children. aged 6 to 12
Parenting Positively Coping with A Parent s Problem Drug or Alcohol Use For children aged 6 to 12 The information in this booklet is meant to help children who are living with harmful parental drug or
More informationCloud Computing: The Gathering Storm
Cloud Computing: Independent research Martin Wootton, RS Consulting Cloud Computing: The Gathering Storm What UK consumers really feel about cloud-based services We rely more than ever on computing and
More informationWould You Like To Earn $1000 s With The Click Of A Button?
Would You Like To Earn $1000 s With The Click Of A Button? (Follow these easy step by step instructions and you will) This Version of the ebook is for all countries other than the USA. If you need the
More informationCorporate Recruiter Tells All
Corporate Recruiter Tells All Tips, Secrets, and Strategies to Landing Your Dream Job! By Ryan Fisher INTRODUCTION It pains me to see so many people working day after day at unsatisfying jobs with limited
More informationArbs2U Is it right for me? 17 October 2014
17 October 2014 Contents Section 1 Preface... 3 Document Feedback... 3 Section 2 Introducing Arbitrage... 4 A brief discussion on Betting... 4 What is Arbitrage?... 5 What are the risks involved?... 7
More informationTackling stigma: Stigmatisation and Barriers to Engagement for problem drug users. Charlie Lloyd Health Sciences University of York
Tackling stigma: Stigmatisation and Barriers to Engagement for problem drug users Charlie Lloyd Health Sciences University of York 1 What is stigmatisation? Stigma = Gk - tattoo or puncture mark branding
More informationInformation for registrants. What happens if a concern is raised about me?
Information for registrants What happens if a concern is raised about me? Contents About this brochure 1 What is fitness to practise? 1 What can I expect from you? 3 How are fitness to practise concerns
More informationUtah Divorce Survival Kit
Utah Divorce Survival Kit An Instruction Manual Prepared by Common Ground Divorce Mediation THIS KIT IS FOR: This kit has been put together by experienced divorce professionals for couples who desire to
More informationSupporting relatives and informal carers top tips for mental health workers
Supporting relatives and informal carers top tips for mental health workers These top tip cards have been produced in partnership by NHS Education for Scotland and Support in Mind Scotland. NHS Education
More informationGUIDE TO PATIENT COUNSELLING
Guide To Patient Counselling page - 1 - GUIDE TO PATIENT COUNSELLING Communication is the transfer of information meaningful to those involved. It is the process in which messages are generated and sent
More informationHOW TO USE VIDEO TO MOTIVATE LEARNING
HOW TO USE VIDEO TO MOTIVATE LEARNING Catherine de Salvo Director, Scott Bradbury Ltd. trainingzone How do you use video to motivate learning? If you are considering using video as part of your online
More informationDrug & Alcohol Star. Not for use. Want to use this Star? Visit www.outcomesstar.org.uk/support
User Guide Drug & Alcohol Star TM The Outcomes Star for drug and alcohol recovery drug use 0 0 0 alcohol use physical health meaningful use of time Contact info@triangleconsulting.co.uk Developed by Sara
More informationBehaviourally Based Questions
Behaviourally Based Questions Index 1 HOW TO WRITE BEHAVIOURALLY BASED QUESTIONS Page 2 2 SAMPLE BEHAVIOURAL QUESTIONS Page 3 3 SAMPLE BEHAVIOURALLY BASED QUESTIONS FROM RIGHT JOB, RIGHT PERSON! CAPABILITY
More informationPatient Information Sheet
Healthcare Worker exposure to a patient s blood What is a healthcare worker exposure? Patient Information Sheet Occasionally, health care workers come into contact with the blood or body fluids of their
More informationInjury Management. Making it Work. Injury Management Making it Work 1
Injury Management Making it Work Injury Management Making it Work 1 Please note This information is for guidance only and is not to be taken as an expression of the law. It should be read in conjunction
More informationYoung people and drugs
Young people and drugs Many parents worry about whether their son or daughter is taking illegal drugs, how they can tell, and what to do about it. While there s a lot of concern about illegal drugs in
More informationHow To Tell Someone You Are An Hiv Or Aids Positive
HIV/AIDS DISCRIMINATION Are You Breaking The Law? HALSA HIV & AIDS Legal Services Alliance Produced by the City of Los Angeles Department on Disability, AIDS Coordinator s Office HIV/AIDS DISCRIMINATION
More informationJoanne Lush, AIDS Bureau, Ministry of Health & Long-Term Care Maria Hatzipantelis, Ontario HIV Treatment Network
OHTN Research Conference, Nov 11-13, 2012 Joanne Lush, AIDS Bureau, Ministry of Health & Long-Term Care Maria Hatzipantelis, Ontario HIV Treatment Network Evaluation background Evaluation purpose Methods
More informationWhy Your Job Search Isn t Working
Why Your Job Search Isn t Working 6 mistakes you re probably making and how to fix them I t s easy to think that your lack of success in finding a new job has nothing to do with you. After all, this is
More informationTop Ten Things to Know About Stem Cell Treatments
Top Ten Things to Know About Stem Cell Treatments Many clinics that are offering stem cell treatments make claims about what stem cells can and cannot do that are not supported by our understanding of
More informationMilitary and Substance Abuse Dr. Amy Menna & Gift From Within
1 Military and Substance Abuse Dr. Amy Menna & Gift From Within This article is meant to assist soldiers and those who support them to identify the differences between substance abuse and addiction. In
More informationThe Many Emotions of Grief
The Many Emotions of Grief While it is important to understand grief and know how it can affect us, we must also acknowledge that: The focus of grief is not on our ability to understand, but on our ability
More informationMaking sense of cognitive behaviour therapy (CBT)
Making sense of cognitive behaviour therapy (CBT) Making sense of cognitive behaviour therapy What is cognitive behaviour therapy? 4 How does negative thinking start? 6 What type of problems can CBT help
More information'Swampy Territory' The role of the palliative care social worker in safeguarding children of adults who are receiving specialist palliative care
'Swampy Territory' The role of the palliative care social worker in safeguarding children of adults who are receiving specialist palliative care This qualitative study explores the role of the palliative
More informationThe ACCURE-UK Trial: The feasibility of undertaking Appendicectomy to impact upon the Clinical Course of UlceRativE Colitis
The ACCURE-UK Trial: The feasibility of undertaking Appendicectomy to impact upon the Clinical Course of UlceRativE Colitis Patient Research Interview Information Sheet ACCURE-UK non-participants Version
More informationNew York State Department of Health. 9413 Rev. 10/05
New York State Department of Health 9413 Rev. 10/05 WHAT YOU NEED TO KNOW ABOUT HEPATITIS C: A GUIDE FOR PEOPLE WITH HIV INFECTION Did you know that in the United States, at least 1 in 4 people with HIV
More informationAnxiety is not an illness that you either have or do not have everyone has experienced anxiety.
Department of Clinical Psychology What is anxiety? Anxiety is not an illness that you either have or do not have everyone has experienced anxiety. We can all remember stressful times when we have felt
More informationReducing Customer Churn
Reducing Customer Churn A Love Story smarter customer contact Breaking up is hard to do The old adage that it s cheaper (and better) to hold onto an existing customer than to acquire a new one isn t just
More informationAustralian Federation of AIDS Organisations
Australian Federation of AIDS Organisations Comments regarding Electronic Health Records and Healthcare Identifiers: Legislation Discussion Paper (Department of Health) 24 June 2015 The Australian Federation
More informationPerformance Management Is performance management really necessary? What techniques are best to use?
Performance Management Is performance management really necessary? What techniques are best to use? This e-book is a guide for employers to help them discover tips and methods of performance management,
More informationCooper Hurley Injury Lawyers
Cooper Hurley Injury Lawyers 2014 Granby Street, Suite 200 Norfolk, VA, 23517 (757) 455-0077 (866) 455-6657 (Toll Free) YOUR RIGHTS WHEN YOU ARE INJURED ON THE RAILROAD Cooper Hurley Injury Lawyers 2014
More informationSNAP: Telling Our Stories, Heroin Assisted- Treatment and Advocacy
SNAP: Telling Our Stories, Heroin Assisted- Treatment and Advocacy NPA PARTICPANT SUPPORT and ADVOCACY In January 2011, Dave Murray with support from Ann Livingston organized a group of participants from
More informationMS Learn Online Feature Presentation Invisible Symptoms in MS Featuring Dr. Rosalind Kalb
Page 1 MS Learn Online Feature Presentation Invisible Symptoms in MS Featuring Dr. Rosalind Kalb >>Kate Milliken: Hello, I m Kate Milliken, and welcome to MS Learn Online. No two people have exactly the
More informationCASE STUDY: MID-MAIN MEETS THE EPR RESULTS FROM THE PRE-EMR PATIENT INTERVIEWS
16 January 2005 CASE STUDY: MID-MAIN MEETS THE EPR RESULTS FROM THE PRE-EMR PATIENT INTERVIEWS Project Co-investigator: Ellen Balka Researcher: Nina Boulus Nicki Kahnamoui FIELDWORK SUMMARY- PHASE 1 -
More information